Madison, Wisconsin-June 19, 2009- Next Generation Clinical Research is proud to announce it has been named one of this year’s recipients of the Dane County Small Business Award. This prestigious award recognizes small businesses in Dane County who are making strong contributions to our communities and economy.
“It is a great honor to be selected as one of the award recipients this year. This is especially exciting as we celebrate our tenth anniversary.” commented Laura L. Douglass, President & CEO of Next Generation.
Next Generation provides services to small and mid-sized pharmaceutical and biotech companies in the development of new drugs. The company manages clinical trials throughout the US and Canada while providing medical safety oversight and data management services. Douglass credits “employee expertise and adaptability” for company’s continued success in a fast paced and highly regulated industry. Next Generation’s work has supported the approval of new medications in areas of neurological disorders and kidney disease. Douglass relayed “It’s exciting to have a role in finding new cures and impacting people’s lives”.
Next Generation was also recognized for their community contributions as the company sponsors high school scholarships and contributes to numerous local charity and volunteer organizations. Next Generation received the award at a breakfast ceremony emceed by Jody Glynn Patrick of InBusiness Magazine with comments by Dane County Executive, Kathleen Falk. The award is coordinated by the University of Wisconsin Small Business Development Center with judges from different industry sectors each year. Award sponsors for 2009 included Centro Hispano, Chase, In Business Magazine, Madison Gas & Electric, Mid-West Family Broadcasting, Urban League of Greater Madison, UW-Madison Small Business Development Center, Wisconsin Business Development Finance Corporation.
ABOUT NEXT GENERATION – Next Generation is a Contract Research Organization (CRO) focused on providing clinical trial management services to small and mid-sized pharmaceutical and biotech organizations. The company was founded in 1999 and conducts novel, complex clinical trial projects throughout the United States and Canada.
Next Generation Clinical Research